Background Estimated glomerular filtration rate (eGFR) is a widely accepted indicator of
renal function. The aim of this study was to evaluate the relationship between eGFR and 3 …

Despite the sharp decline in most high-income industrialized countries, rheumatic heart
disease (RHD) continues to be highly prevalent in many rural, low-and middle-income …

Introduction and objectives Valvular heart disease in patients with atrial fibrillation included
in clinical trials with direct oral anticoagulants (DOAC) is common and is associated with …

摘要背景: 前期研究证实, 迷宫Ⅲ 手术是治疗二尖瓣病变合并持续性或长期持续性心房颤动安全
且有效的方法, 但老年患者手术耐受性差, 有关老年患者行迷宫Ⅲ 手术安全性及有效性的相关 …

Introducción y objetivos Si bien la utilización de anticoagulantes orales directos (ACOD) en
pacientes con fibrilación auricular (FA) y prótesis valvular biológica como alternativa a los …

Non-vitamin K antagonist oral anticoagulants (NOACs) were developed and approved as
substitutes for vitamin K antagonists (VKAs)[1–3]. NOACs have become the preferred …

Doustne leki przeciwkrzepliwe niebędące antagonistami witaminy K (NOAC, non-vitamin K
antagonist oral anticoagulants) wymieniane są w wytycznych dotyczących leczenia …

Figure. Effects of direct oral anticoagulants (DOACs) vs. warfarin on outcomes in patients
with bioprosthetic valves.* Adjusted for heart failure, left ventricular ejection fraction …

Background To date, there has been no study that compares the efficacy and safety of
warfarin in atrial fibrillation (AF) patients with Evaluated Heartvalves, Rheumatic or Artificial …

Aims Rheumatic heart disease (RHD) remains a major global health problem. Renin–
angiotensin–aldosterone system inhibitors (RAASi) are commonly administered in the …